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Abstract Objective: To develop a
new method to evaluate the perfor-
mance of individual ICUs through the
calculation and visualisation of risk
profiles. Methods: The study inclu-
ded 102,561 patients consecutively
admitted to 77 ICUs in Austria. We
customized the function which
predicts hospital mortality (using SAPS
II) for each ICU. We then compared
the risks of hospital mortality result-
ing from this function with the risks
which would be obtained using the
original function. The derived risk
ratio was then plotted together with
point-wise confidence intervals in
order to visualise the individual risk
profile of each ICU over the whole
spectrum of expected hospital
mortality. Main measurements and
results: We calculated risk profiles
for all ICUs in the ASDI data set
according to the proposed method.
We show examples how the clinical
performance of ICUs may depend on
the severity of illness of their patients.
Both the distribution of the Hosmer–
Lemeshow goodness-of-fit test
statistics and the histogram of the
corresponding P values demonstrated
a good fit of the individual risk
models. Conclusions: Our risk
profile model makes it possible to
evaluate ICUs on the basis of the
specific risk for patients to die
compared to a reference sample over
the whole spectrum of hospital
mortality. Thus, ICUs at different
levels of severity of illness can be
directly compared, giving a clear
advantage over the use of the con-
ventional single point estimate of the
overall observed-to-expected
mortality ratio.
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Introduction
Finding a reliable method to quantify the performance of
single ICUs has always been a difficult quest in the last
30 years, despite the fact that the evaluation of clinical
performance is a prerequisite for the assessment of both
the effectiveness and efficiency of care. Furthermore,
increasing cost constraints have focused the attention of
clinicians, managers and researchers on this problem.
Most published approaches to quantifying the perfor-
mance of ICUs adopt more or less the same procedures:
the development of a general outcome prediction model
(GOPM) and its calibration in a suitable database. Such
models are then applied to different cohorts of ICU
patients, and comparison of the predicted number of
deaths with the actual number of deaths is used as a
reference for the clinical performance of the unit. The
resulting quotient (actual number of deaths divided by
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predicted number of deaths) is thus a one-point estimate,
known as the standardized mortality ratio (SMR) or
observed-to-expected mortality ratio (O/E). If this ratio is
significantly lower than 1, then the performance of the
specific ICU being evaluated is judged to be better than
that of the ICUs from which the GOPM was derived; if it
is significantly higher than 1, the performance of the ICU
is judged to be worse.
Using several GOPMs, such as APACHE II [1],
APACHE III [2], APACHE IV [3], SAPS II [4] or SAPS
3 [5], this methodology has become the ‘‘gold standard’’
to compare ICUs across different geographical areas or
inside the same country, or other specific subgroups of
patients. Several limitations of the SMR approach,
including patient-, user-, and model-dependent problems,
have been described and discussed in detail [6]. But there
is another weakness: a one-point estimate considers the
performance of an ICU to be constant over the whole
spectrum of the severity of illness. In other words, an ICU
with a ‘‘good’’ performance (low SMR) is assumed to be
uniformly good for both low-risk and high-risk patients;
likewise, an ICU with a ‘‘bad’’ performance (high SMR)
is assumed to be uniformly bad. However, this assump-
tion is most probably not true, since performance might
differ over the spectrum of the severity of illness.
The objective of this work was to develop a new
method to evaluate the clinical performance of ICUs, on
the assumption that clinical performance might be vari-
able over the spectrum of severity of illness of the
admitted patients. In this report we present several
examples of risk profiles for ICUs using data aggregated
between 1998 and 2007.
Methods
The study used the database of the Austrian Center of
Documentation and Quality Assurance in Intensive Care
Medicine (ASDI), a nonprofit organization that has
established an intensive care database and benchmarking
project in Austria. The prospectively collected data
included sociodemographic data, such as age, sex and
chronic conditions; reason for admission, which was
recorded according to a predefined list of medical and
surgical diagnoses; severity of illness, as measured by
SAPS II [4]; length of ICU stay and hospital stay; and
outcome data, including survival status at ICU and hos-
pital discharge.
Data on all patients consecutively admitted to 77
Austrian ICUs between January 1, 1998, and December
31, 2007, were included in this study. A total of 176,703
admissions occurred during the study period. For read-
mitted patients, only the first admission was included,
leaving 168,194 patients. Patients who were\18 years of
age (n = 3,292), those with records that lacked an entry
in the field ‘‘hospital outcome’’ (n = 6,904) and those
without a valid SAPS II score (n = 1,313) were further
excluded.
To avoid over- or underestimating the relative risks for
patients in the extremely low and extremely high risk
areas, we also excluded patients with a predicted hospital
mortality of \5% (n = 52,181) or [95% (n = 1,937).
Predicted mortality was based on the original SAPS II risk
model. Consequently, the cohort under study consisted of
102,561 patients from 77 ICUs. Since no additional
interventions were performed, the need for informed
consent was waived by the institutional review board.
Using SAPS II [4], we customized the function which
predicts hospital mortality at ICU admission for each
ICU. We used simple customization in complete samples.
The risks of hospital mortality resulting from this function
were then compared with the risks which would be
obtained using a reference cohort. As reference we used
the original function from the SAPS II publication applied
to the ASDI cohort. By dividing the risk obtained from
the ICU-specific function by the risk obtained from the
general function, we were able to determine the difference
in the risk of dying in the hospital for patients in indi-
vidual ICUs over the continuum of 5–95% predicted risk.
The logistic regression-derived risk ratio was then
graphically plotted, together with its confidence intervals.
Conventional point-wise 95% confidence intervals for the
risk ratios were calculated from the customized logistic
models assuming that the expected risk from the original
SAPS II risk model in the denominator is a non-random
quantity.
The result is a risk profile of each ICU over the whole
span of the probability of hospital mortality. This method
thus allows a direct comparison of individual risk profiles
for specific ICUs. Using a simple two parameter risk
model with a form closely related to the model used
originally when constructing the SAPS II risk score
achieves smoothing of the individual risk profiles with
corresponding confidence intervals in moderately small
samples. This is thus different to calculating ICU-specific
risk ratio estimates in risk decile groups with even much
smaller sample sizes (and potentially wide confidence
intervals).
To evaluate the performance of these risk profiles, we
compared their results with those estimated by nonpara-
metric methods through the use of LOWESS curves
(SAS, Proc LOWESS). We used three different methods
for this purpose: first, a graphical distribution of the
Hosmer–Lemeshow goodness-of-fit test per ICU per year,
which (for a perfect fit) approximately should follow a
chi-square distribution with 8 degrees of freedom (df).
Second, a histogram of the corresponding P values per
ICU per year. Third, a display of the corresponding
LOWESS curves together with the regression-based
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estimates for each ICU to allow for visualization of the
results.
Results
A total of 102,561 patients were included in the study.
The 77 ICUs provided a median number 1,135 (inter-
quartile range 512–1,905) patients per ICU. Median age
of the patients was 70 (60–79) and 44% were female.
Roughly half of the admissions were medical admissions
(Table 1). Chronic cardiac failure was the leading
comorbidity (17.8%), followed by chronic renal failure
(8.9%), metastatic cancer (6.1%) and insulin-dependent
diabetes mellitus (6.1%).
Figure 1 shows (as an explanatory example) the
association between the SAPS II score and the predicted
hospital mortality for the reference cohort and for a spe-
cific ICU (the same ICU as in Fig. 2a). The risk of dying
in the hospital for a patient with a SAPS II score of
approximately 29 was 10% in the reference cohort, but
roughly 17% in the individual ICU. Dividing the risk in
the ICU by the risk in the reference cohort, we obtained
the risk ratio as depicted in Fig. 2a: in this case, 1.7 for
the risk point of 0.1 on the x-axis, which corresponds to
the increased risk of dying as outlined above. This risk
ratio was calculated for the whole span of the severity of
illness.
Calculating the risk profiles for all ICUs from the
ASDI database we found several units whose
performance depended on the severity of illness of its
patients. Figure 2 gives some examples of different rela-
tionships between the actual risk of dying in a specific
ICU and the risk predicted in the reference cohort.
Figure 2a shows data for an ICU in which clinical per-
formance increased as the severity of illness increased,
i.e., fewer patients died than expected. Thus, this ICU
performed better with high-risk patients. The opposite
was true for the example shown in Fig. 2b, in which
clinical performance decreased as the severity of illness
increased; more patients died than expected in the upper
risk area. Thus, this ICU performed better with low-risk
patients. Figure 2c shows the example of an ICU in which
clinical performance was stable over the whole spectrum
of the severity of illness.
Figure 2 shows the results for three individual ICUs
aggregated over a time period up to 10 years. In order to
get an impression of the variability of the risk profiles in
smaller samples Figure E1 in the electronic material
provides the corresponding results of the same three ICUs
broken down to calendar years (altogether 504 samples).
The most interesting result is that the different types of
risk profiles for specific ICUs seem to remain surprisingly
stable over the years in the ICUs.
Comparing the risk profiles estimated by our risk
profile model with those estimated by nonparametric
methods (LOWESS curves), we found a satisfactory fit of
the risk profile model: results from the simple two
parameter risk model in general are rather closely fol-
lowing the profile resulting from nonparametric
smoothing of an arbitrary type of profile (Fig. 2; Figure
E1). The histograms for the Hosmer–Lemeshow good-
ness-of-fit test statistics per ICU per year showed
excellent agreement with the density of the chi-square
distribution with 8 df (Fig. 3a). The histogram of the
Table 1 Characteristics of the study subjects
Percentage
Number of patients 102,561 100
Number of ICUs 77 100
Patients per ICU 1,135 (512–1,905)
Age (years) 71.0 (60.0–79.0)
Sex
Female 44,738 43.74
Male 57,540 56.26
Missing 283
ICU length of stay (days) 4.00 (2.00–9.00)
Total number of days in the ICU 873,776
Outcome
SAPS II score 36.0 (28.0–49.0)
SAPS II predicted mortality 29,484 28.75
Observed ICU mortality 16,801 16.38
Observed hospital mortality 24,642 24.03
Type of admission
Medical 52,379 51.22
Scheduled surgical 24,570 24.03
Unscheduled surgical 25,307 24.75
Missing 305
SAPS II O/E ratio 0.836 (0.828–0.844)
All data are given as median with interquartile ranges if not
otherwise expressed
Fig. 1 Association between SAPS II score and predicted mortality
in the reference cohort and a single ICU. The blue line represents
the relationship between the SAPS II score and the predicted
probability of death using the original SAPS II function. The green
line represents the customized function for the specific ICU
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corresponding P values was also plotted (Fig. 3b). For a
perfect fit in independent samples the distribution should
be uniform between 0 and 1. As can be seen in Fig. 3b,
there was no obvious tendency toward low P values
(which would be expected for a lack of fit), and thus we
can conclude that the risk profile model again demon-
strates a sufficient fit.
To see how the model works if all patients are inclu-
ded in the analysis (including those below 5 and above
95% risk) we repeated the calculations for the whole
sample (n = 156.679) (with arbitrary expected risk) ful-
filling the inclusion criteria. Figures E2, E3 and E4 in the
electronic material, give the corresponding results for the
same ICUs as in Fig. 2a–c in this manuscript, respec-
tively. Overall the fit in the full samples tends to be a little
worse at the extreme ends of the risk scale (as could be
awaited), but the confidence intervals are narrower due to
the larger sample sizes particularly in the low risk area.
Discussion
Unlike the one-point estimate used in the classical SMR
approach, the model presented here provides a graphic
representation of the risk profile for any ICU over the
whole spectrum of predicted hospital mortality. Contrary
to the classical view, in which clinical performance is
assumed to be the same in all risk groups, we tested and
accepted the hypothesis that performance can vary not
only between ICUs, but also within the same ICU,
according to the severity of illness of the admitted
patients.
As shown in Fig. 2, variations in clinical performance
do exist. In an attempt to address this problem, investi-
gators analyzed the EURICUS-I study database [7] by
deriving three performance variables for each ICU: P20
(performance with low-risk patients, evaluated at the 20th
percentile), P50 (performance with medium-risk patients,
evaluated at the median) and P80 (performance with high-
risk patients, evaluated at the 80th percentile). This
method, based on customization of the SAPS II score for
each ICU using logistic regression with random effects,
allowed the user to compare the performance of an ICU at
least three different points. However, this method was
never widely used. Similar results were obtained during
the development of the SAPS 3, when the relationship
between severity of illness and actual mortality was found
to differ greatly between different geographical areas [6].
The conceptual and practical limitations of the concept
that clinical performance is independent of severity of
illness cannot be overemphasized, because the implica-
tion (used by all current GOPMs) is, that performance is
Fig. 2 Examples of different relationships between the perfor-
mance of the ICU and the severity of illness of the admitted
patients. The thick blue lines represent the risk profile model. The
thinner blue lines represent the confidence interval. The black lines
represent the associated LOWESS curve. Data were aggregated
between 1998 and 2007. a ICU in which the clinical performance
increased as the severity of illness increased. b ICU in which the
clinical performance decreased as the severity of illness increased.
c ICU in which the clinical performance was almost independent of
the severity of illness
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stable—that ICUs always perform badly or well. How-
ever, as we demonstrate here, performance may even vary
within ICUs. This is true not only for variations over time
[8], but also over the spectrum of severity of illness. This
means that the same ICU can present a good performance
when dealing with patients with low severity of illness
and a poor performance with patients with high severity
of illness, or vice versa. When looking at the variation of
such profiles over calendar years, we saw examples of
ICUs with surprisingly stable profiles (Figures E1, E4).
The challenge is thus to first understand why this phe-
nomenon occurs and then to determine which factors
(clinical or nonclinical) are responsible for these varia-
tions in performance.
Most ICUs have been designed to deal with a certain
type of patient and a certain number of patients and thus
are equipped with the technical and human resources
strictly necessary for this task. What happens, however, if
this capacity is overextended? There is good evidence that
several operational factors affect the outcome of critically
ill patients, such as high nursing workload [9], increased
occupancy rate [10], and patient turnover [11]. However,
the opposite could also be true: an ICU that is used to deal
with very critically ill patients could have a worse per-
formance when only low-risk patients are admitted. This
could be explained in part by the overmonitoring and
overtreating of patients, which has been shown to affect
outcome as well [12, 13].
For purposes of risk adjustment, we used the SAPS II
system in this study. However, it should be emphasized
that any risk prediction model which allows for a trans-
formation of the score into a predicted risk of death could
be used. We used SAPS II because it is available—it is
scored on a mandatory basis in Austria. We also tested the
risk profile model in the SAPS 3 database and found good
results there as well (data not shown). However, the
number of observations in the ASDI database is much
higher because of the long period of data collection, and
thus we decided to present those data here. Anyway,
further studies using other risk adjustment systems should
be undertaken.
Moreover, we used the original SAPS II equation as a
reference in this study. This could be questioned, since it
is well known that the original equation overestimates
hospital mortality in Austrian ICU patients [the O/E ratio
for the original SAPS II from the same cohort is 0.841
(0.834–0.849)]. Since we do not compare single O/E
mortality ratios, this deviation does not really distort our
results. For future studies, however, the reference data-
base (and thus the reference function for the prediction of
hospital mortality) could be chosen according to the
purpose of comparison: if necessary, regionally custom-
ized functions (when available, e.g., in the SAPS 3
system) could be used instead or in addition.
We excluded patients within the extremely low and
extremely high risk areas, i.e., those with a predicted
mortality of \5 or [95%. Although the number of
patients excluded seems to make up a substantial pro-
portion of the whole cohort, the numbers diminish if the
relatively high number of ICUs is taken into account. The
exclusion seems to be advisable, since low numbers of
patients with extreme risks would affect the values of the
expected risk in the denominator and thus distort the
results of the model. For this reason we decided first to
develop the model applying this restriction.
However, even in the unrestricted patient population,
the model produces very reasonable profiles with mod-
erately narrower confidence intervals (due to the
Fig. 3 Evaluation of the risk profile model. a Histogram of the
Hosmer–Lemeshow goodness-of-fit test statistics per ICU per year
(in total 504 samples) from the SAPS II analyses. The curve
indicates the density of the chi-square distribution with 8 df, the
distribution to be expected approximately for the case of a perfect
fit in independent samples. b Histogram of the corresponding
P values, which for a perfect fit in independent samples should
approximately follow a uniform distribution between 0 and 1. Also,
there is no obvious tendency toward low P values (lack of fit)
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increased sample sizes). In future it should be the quality
of prediction in extreme risk categories of the underlying
risk model which should taken as a basis for the decision,
if at all and how any truncation should be performed.
In conclusion, our results, derived from a large cohort
of critically ill patients, provide conclusive evidence that
the clinical performance of ICUs may vary over the
spectrum of severity of illness. These results provide the
rationale to further investigate the association between
these variations happening and organizational factors, so
as to detect possibilities to improve the care we deliver to
our patients.
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